Trial intelligence / Profile preview

MoviPrep versus Colopeg for colonoscopy preparation

2006-006873-25Phase 4Completed

Sponsor
Norgine
Start
Feb 2007
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of macrogol (2 arms), sponsored by Norgine. Primary endpoint: Successful colon cleansing rate. Started Feb 2007; status: completed.

02

Drugs

macrogol

Beyond the preview

Go deeper on 2006-006873-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006873-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call